Contribution: Industrial Research Assistance Program – Contributions to Firms
CANADIAN NANO PHARMACEUTICAL TECHNOLOGY INC.
$140,000.00
Development and Characterization of First-Generation Sustainable Nano Drug Delivery Platforms for Topical Personalized Medicine and Skincare
FY 2025-26 · 2025-04-01
Summary
The project involves optimization of a proprietary drug delivery platform for seamless integration with key active pharmaceutical ingredients (APIs) in topical and transdermal formulations. Activities also include characterization studies of scaled-up materials for potential commercialization.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Richmond|Richmond, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
797348687
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2025-04-01 | 2025-26 | $125,000.00 |
| 1 | 2025-04-01 | 2025-26 | $140,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 15,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 15 000 dollars.
Agreement End Date
2026-03-31
Agreement Number
1030461
Agreement Start Date
2025-04-01
Agreement Title
Development and Characterization of First-Generation Sustainable Nano Drug Delivery Platforms for Topical Personalized Medicine and Skincare
Agreement Title (French)
Développement et caractérisation de plateformes de nanotransporteurs de médicaments durables de première génération pour la médecine personnalisée topique et les soins de la peau.
Agreement Type
Contribution
Agreement Value
$140,000.00
Amendment Date
2025-11-24
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project involves optimization of a proprietary drug delivery platform for seamless integration with key active pharmaceutical ingredients (APIs) in topical and transdermal formulations. Activities also include characterization studies of scaled-up materials for potential commercialization.
Description (French)
Le projet comprend l’optimisation d’une plateforme de délivrance de médicaments exclusive pour une intégration transparente avec les principaux ingrédients pharmaceutiques actifs (API) dans les formulations topiques et transdermiques. Les activités comprennent également des études de caractérisation des matériaux mis à l’échelle en vue d’une commercialisation potentielle.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Richmond Centre
Federal Riding (French)
Richmond-Centre
Federal Riding Number
59025
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
797348687
Recipient City
Richmond|Richmond
Recipient Country
CA
Recipient Legal Name
CANADIAN NANO PHARMACEUTICAL TECHNOLOGY INC.
Recipient Operating Name
CNano
Recipient Postal Code
V7C 2M2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q1-1030461
